Sun Pharma Advanced Research Company Limited (NSE:SPARC)
India · Delayed Price · Currency is INR 138.51
+1.21 (0.88%)
Dec 12, 2025, 10:15 AM IST
NSE:SPARC Market Cap
NSE:SPARC has a market cap or net worth of 44.56 billion as of December 11, 2025. Its market cap has decreased by -32.10% in one year.
Market Cap
44.56B
Enterprise Value
48.71B
Revenue
595.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
138.51
Market Cap Chart
Since July 18, 2007, NSE:SPARC's market cap has increased from 17.19B to 44.56B, an increase of 159.25%. That is a compound annual growth rate of 5.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 44.56B | -31.54% |
| Dec 31, 2024 | 65.08B | -30.07% |
| Dec 29, 2023 | 93.07B | 62.05% |
| Dec 30, 2022 | 57.43B | -24.01% |
| Dec 31, 2021 | 75.58B | 48.86% |
| Dec 31, 2020 | 50.77B | 24.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.28T |
| Divi's Laboratories | 1.67T |
| Cipla | 1.20T |
| Apollo Hospitals Enterprise | 1.01T |
| Zydus Lifesciences | 929.36B |
| Mankind Pharma | 899.98B |
| Aurobindo Pharma | 681.05B |
| Alkem Laboratories | 669.38B |